Georgetown Pharmacology
Program Overview
Faculty and Research
Graduate Studies
News and Information

 

 

       
  

R. Scott Turner

Professor of Neurology
Director, Memory Disorders Program
 
Ph.D., Pharmacology,
Emory University 1984
M.D., Emory University, 1988
Pennsylvania State University, 1987


rst36@georgetown.edu

                                      

The focus of our research is on the molecular mechanism of Alzheimer's disease (AD). One ongoing project (at the Univ. of Michigan and Georgetown Univ.) is probing the effects of the neuronal adaptor protein X11alpha/mint-1 on amyloid precursor protein (APP) trafficking and processing--using crosses of trangenic and knockout mice.  In collaboration with Dr. Rebeck's group, we also plan to explore the role of X11alpha/mint-1 on ApoE receptor trafficking, and function, in neurons (including dendritic spines).  Another project focuses on passive immunization of a triple transgenic AD mouse (transgenic for hAPP, hPS1, and hTau).  Experiments are designed to probe the mechanisms, and efficacy of novel anti-amyloid monoclonal antibodies to clear amyloid plaques in brain, and to rescue behavioral phenotypes in aged mice.  The potential risks of passive immunization in AD transgenic mice, such as microhemmorhages, are also being explored.


Selected Publications:

Click here to do a Medline Search for all publications of Scott Turner